World’s first AI orchestrator data platform for healthcare launches and more

Health Tech World explores the latest business developments in the world of health technology.

The world’s first AI orchestrator data platform for healthcare launches

McCrae Tech has launched the world’s first health AI orchestrator called Orchestral.

Orchestral is a health-native AI orchestrator data platform that connects diverse data sources with AI agents, workflows, and algorithms, enabling scalable, governed AI deployment across healthcare systems.

“Most information technology in healthcare falls into two camps: either a big, dumb bucket of cloud data or isolated pockets of AI cleverness,” said Ian McCrae, founder of McCrae Tech.

“We have created something vastly different that reshapes healthcare as we know it.”

Orchestral integrates three core components.

These include a Health Information Platform (HIP) which ingests data from any source and delivers trusted, structured, standardized, and compliant health data.

A Health Agent Library (HAL) which provides a governed registry of AI building blocks for the entire health system, and a Health AI Tooling (HAT) which enables data analysts and scientists to build agentic workflows, business intelligence reports, and more.

“Simply swamping clinicians with more data is not the answer to improve healthcare. Extra data may contain useful insights, but these are needles in a haystack without the necessary AI tooling to extract them into human-understandable observations.

“Orchestral delivers exactly that, enabling healthcare providers to harness AI’s full potential. Its potential impact on global health is comparable to the transformative shifts brought about by antibiotics, modern hygiene, and other breakthrough public health innovations,” says McCrae.

Infinitus launches next-generation clinical AI agents

Infinitus Systems has launched its next generation of clinical AI agents for patient-facing conversations.

These new agents provide an intelligent and secure solution for healthcare organisations to augment their care teams through patient education, care management, health risk assessments, and other clinical patient communication needs.

Infinitus research shows that 43 per cent of people have had a question that they were too embarrassed to ask a doctor, nurse or other healthcare worker, and that 83 per cent of patients who have had questions for their provider in the wake of a diagnosis have them after hours.

By offering natural, human-like interactions, Infinitus’ new generation of agents brings personalisation while also equipped with capabilities that safely and effectively extend care teams for health systems, plans and providers.

“Our next-generation clinical agents usher in a new era for patients, one of trusted and empathetic interactions that can meet them where they are and when they are in need,” said Ankit Jain, CEO and co-founder of Infinitus.

“Built on a foundation of robust data and evaluation criteria, Infinitus’ clinically aware agents deliver the highest-quality, agentic patient experience and empower clinicians and care teams to extend their reach without adding to their workload.”

Infinitus’ clinical agents use natural speech patterns, tone and timbre, and awareness of medical concepts and terminology is built in, allowing the agents to understand clinical intent, evaluate symptom severity, and manage medications according to protocols set by the patient’s care team.

The agents’ clinical awareness enables them to detect medical emergencies and adverse events, and escalate to professionals as needed, though all key details from conversations are always communicated back to the patients’ care team so clinical staff can follow up.

“As a physician, I know how important it is to spend as much time with patients as they need, to address their concerns and make sure they feel heard, and yet, as providers, too often we don’t have that kind of time,” said Erin Palm, chief medical officer at Infinitus.

“This is why I’m thrilled by the launch of our newest clinical agents and their potential impact on patients’ healthcare experiences and, ultimately, their outcomes.

“By using Infinitus’ innovative technology for clinical purposes, we’re able to bring relief to overworked healthcare providers while simultaneously easing the burden for patients along their healthcare journeys.”

When tested for fairness and equity in conversations with patients, Infinitus’ clinical agents showed no differences in accuracy rates across different age cohorts or genders, and no trend with the Social Vulnerability Index (SVI).

This analysis also revealed that more than 50 per cent of the patient population served were over the age of 65, and more than 25 per cent live in areas designated in the highest category of social vulnerability.

Vektor Medical receives FDA 510(k) clearance adding new capabilities to next-generation vMap

Vektor Medical has received FDA 510(k) clearance for its next-generation vMap technology.

The clearance expands vMap’s non-invasive mapping capabilities with several major enhancements, including atrial flutter mapping, direct ECG and data streaming with electroanatomic mapping systems, 3D model import and visualisation, conversion of vMap into a Software as a Medical Device (SaMD), and local and remote connectivity to support secure data exchange.

With this clearance, vMap’s clinical use now includes non-invasive localisation of potential arrhythmia sources associated with atrial flutter mechanisms.

This new capability broadens the range of arrhythmias that can be addressed using vMap, enabling clinicians to evaluate both atrial and ventricular arrhythmias using a single, rapid, non-invasive mapping solution.

“Receiving this new FDA clearance for our next-generation vMap is a major milestone for our product capabilities and reflects our continued focus on advancing vMap in ways that support EPs in their day-to-day work,” said Rob Krummen, CEO of Vektor Medical.

“Connectivity is essential for scalability. By enabling more seamless data flow, we are helping EPs access arrhythmia insights faster to make informed decisions with greater confidence and support more efficient procedures, all of which contribute to better patient outcomes.

“We will begin rolling out the enhanced vMap technology to U.S. customers over the next several months extending the clinical and operational benefits of a more connected vMap.”

First clinical cases of total knee replacement system

restor3d, a 3D-printing company developing personalised orthopedic solutions, has announced the successful completion of the first clinical cases using the iTotal Identity CR 3DP Porous Fully Personalized Total Knee Replacement System.

The inaugural procedure was performed by William J. Berghoff, at Parkview Orthopedic Hospital in Fort Wayne, Indiana, marking a major milestone in the system’s limited market release and the next evolution of personalised knee arthroplasty.

The iTotal Identity CR 3DP Porous System represents the first fully personalised, cementless total knee replacement offering within the Identity platform, following FDA 510(k) clearance earlier this year.

Built on restor3d’s proven digital-to-implant design workflow, the system integrates CT-based planning, automated personalisation, and advanced 3D-printed porous structures on all metallic components to deliver optimal fit, fixation, and function for every patient.

“It’s remarkable to see a fully personalised, cementless knee replacement come to life in the operating room,” said Dr. William J. Berghoff.

“The combination of patient-specific design and a truly advanced porous architecture provide a level of stability, coverage, and precision that is unlike anything we’ve used before. My patients had an excellent experience, and I’m excited about what this technology means for the future of knee replacement.”

The cementless system leverages restor3d’s proprietary TIDAL Technology on the tibia, femur, and patella implants.

This next-generation porous architecture is engineered to achieve optimised osseointegration strength, enhanced fatigue resistance, and efficient load distribution.

The tibial baseplate, designed to individual patient anatomy, provides optimal bone coverage without sacrificing component rotation, critical for successful cementless fixation. The femoral component preserves each patient’s native joint mechanics through restoration of their individual J-curves.

Delivered in a sterile, single-use kit, the system also incorporates a pre-navigated surgical workflow, reducing intraoperative variability and streamlining operating room efficiency.

By eliminating intraoperative adjustments associated with traditional implant sets, surgeons can rely on a consistent and reproducible implantation experience tailored to each patient’s anatomy.